试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
1200×813
www.modernretina.com
Study: Researchers discover a key failure in AMD that may lead to p…
1200×790
www.modernretina.com
EyePoint Pharmaceuticals sells YUTIQ® to Alimera Sciences, Inc…
1920×1080
www.modernretina.com
OPT-302 VEGF-C/D “trap” molecule for AMD promising in Phase 2b, moves to P…
1200×651
www.modernretina.com
jCyte, Inc. announces pivotal trial of jCell for RP to start in second half of 2024
1200×317
www.modernretina.com
jCyte, Inc. announces pivotal trial of jCell for RP to start in second half of 2024
1801×329
www.modernretina.com
Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in ...
2131×383
www.modernretina.com
Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in ...
1200×764
www.modernretina.com
Altos Biologics submits Marketing Authorization Application to the EM…
1200×674
www.modernretina.com
Phase 3 OAKS and DERBY studies show clinically meaningful reduction in GA lesio…
1200×800
www.modernretina.com
Clearside Biomedical starts enrollment of participants in its OD…
1200×800
www.modernretina.com
ASRS 2023: Not all full-thickness macular holes require surgery; blu…
1280×720
www.modernretina.com
Clinical Trials at the Summit 2023: Choosing right metrics and avoiding bias in clinical tri…
3840×2160
www.modernretina.com
Espansione Group shares preliminary results from LightWave I, a multicentric, randomize…
1200×800
www.modernretina.com
OliX Pharmaceuticals announces positive results of phase 1 study of …
940×788
www.modernretina.com
ASRS 2023: Presenters share what research at the …
1200×800
www.modernretina.com
Espansione Group announces second major research effort for photobiomod…
1900×1286
www.modernretina.com
Rezolute announces initiation of a phase 2 study of RZ402 in patients w…
1200×795
www.modernretina.com
FDA grants orphan drug designation for HG004, HuidaGene’s gene therapy fo…
1200×840
www.modernretina.com
FDA gives clearance of IND for SK0106, Skyline Therapeutics’ AA…
1080×1080
www.modernretina.com
Questions in Ophthalmology: What …
1200×702
www.modernretina.com
Complement Therapeutics completes Series A funding with €72 Million, a step toward …
1280×720
www.modernretina.com
EURETINA 2023: The Real-World Efficacy and Safety of Faricimab in Neovascular AM…
1200×720
www.modernretina.com
Research on the Noelin family of secreted proteins may shed light on blinding condi…
2363×3225
www.modernretina.com
DOVETAIL study: Anti–IL-6 monocl…
1200×800
www.modernretina.com
EXN407 meets endpoints in Phase Ib/IIa trial for diabetic macular edema
1226×690
www.modernretina.com
Retina Society 2023: Personalized faricimab dosing shows promise in extending wet AMD treatment ...
1200×900
www.modernretina.com
Apellis Pharmaceutical to share data during oral presentations at ASRS 20…
1726×974
www.modernretina.com
APAO 2023: Looking at anatomic outcomes in matched comparison: TE…
1200×702
www.modernretina.com
Stuart Therapeutics announces issuance of patent covering ophthal…
1347×641
www.modernretina.com
Foundation Fighting Blindness to host PRPH2 and Associated Retinal Diseases …
1200×800
www.modernretina.com
Unity Biotechnology announces results from Phase 2 ENVISIO…
1200×673
www.modernretina.com
Ranibizumab-eqrn, a biosilimar by Coherus BioSciences, exceeds 100,000 doses in first year
1200×1800
www.modernretina.com
Enrollment complete for Ey…
1200×803
www.modernretina.com
Photobiomodulation: Promising future for treating drusenoid pigment epithelial deta…
1200×798
www.modernretina.com
Alkeus announces $150 Million Series B Financing to support gildeuretinol (ALK-0…
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈
反馈
.png%26w%3d1200%26q%3d75&cdnurl=https%3a%2f%2fth.bing.com%2fth%2fid%2fR.af6a4956cbe5e896e1314723b01554a0%3frik%3dwH9cT%252bUrrMIrHQ%26pid%3dImgRaw%26r%3d0&exph=317&expw=1200&q=site%3awww.modernretina.com&simid=608012098469564177&FORM=IRPRST&ck=8F7CA99132C4E48925FE6B4441A66558&selectedIndex=4&itb=1){kind=logo}
